Qiagen has acquired CLC Bio, a privately held bioinformatics software company headquartered in Aarhus, Denmark.
The news was first reported on AllSeq's blog. GenomeWeb independently confirmed the information with a source familiar with the deal. A CLC Bio official declined to comment. Qiagen did not respond to requests for comment as of press time.